Here we have a signal for Solve.care (SOLVEBTC)
Looking at how strong the move in May was... We can experience something similar on the next wave.
------------
Solve.Care | SOLVEBTC
BUY: 0.00001350 - 0.00001500
TARGET:
1) 0.00001710
2) 0.00001950
3) 0.00002121
4) 0.00002600
5) 0.00003000
6) 0.00003700
7) 0.00004040
8) 0.00005100
9) 0.00005700
POTENTIAL PROFITS: 299%
STOP: Close weekly below 0.00001300.
----------
This is not financial advice.
Make sure to do your own research and have a plan/strategy before trading.
Feel free to hit LIKE to show your support and let us know if you want more posts /trade ideas like this one.
Namaste.
Looking at how strong the move in May was... We can experience something similar on the next wave.
------------
Solve.Care | SOLVEBTC
BUY: 0.00001350 - 0.00001500
TARGET:
1) 0.00001710
2) 0.00001950
3) 0.00002121
4) 0.00002600
5) 0.00003000
6) 0.00003700
7) 0.00004040
8) 0.00005100
9) 0.00005700
POTENTIAL PROFITS: 299%
STOP: Close weekly below 0.00001300.
----------
This is not financial advice.
Make sure to do your own research and have a plan/strategy before trading.
Feel free to hit LIKE to show your support and let us know if you want more posts /trade ideas like this one.
Namaste.
交易开始
🚨 LIFETIME (Pay 1, Get 7)
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
相关出版物
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。
🚨 LIFETIME (Pay 1, Get 7)
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
相关出版物
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。
